These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. An open-label, randomized crossover study to evaluate the acceptability and preference for contraceptive options in female adolescents, 15 to 19 years of age in Cape Town, as a proxy for HIV prevention methods (UChoose). Gill K; Happel AU; Pidwell T; Mendelsohn A; Duyver M; Johnson L; Meyer L; Slack C; Strode A; Mendel E; Fynn L; Wallace M; Spiegel H; Jaspan H; Passmore JA; Hosek S; Smit D; Rinehart A; Bekker LG J Int AIDS Soc; 2020 Oct; 23(10):e25626. PubMed ID: 33034421 [TBL] [Abstract][Full Text] [Related]
7. Systems Analysis Reveals Contraceptive-Induced Alteration of Cervicovaginal Gene Expression in a Randomized Trial. Balle C; Gupta PM; Tharp GK; Nelson SA; Konstantinus IN; Lennard K; Jaumdally SZ; Happel AU; Barnabas SL; Gill K; Bekker LG; Passmore JS; Jaspan HB; Bosinger SE Front Reprod Health; 2022; 4():781687. PubMed ID: 36303659 [TBL] [Abstract][Full Text] [Related]
8. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis. Morrison CS; Chen PL; Kwok C; Baeten JM; Brown J; Crook AM; Van Damme L; Delany-Moretlwe S; Francis SC; Friedland BA; Hayes RJ; Heffron R; Kapiga S; Karim QA; Karpoff S; Kaul R; McClelland RS; McCormack S; McGrath N; Myer L; Rees H; van der Straten A; Watson-Jones D; van de Wijgert JH; Stalter R; Low N PLoS Med; 2015 Jan; 12(1):e1001778. PubMed ID: 25612136 [TBL] [Abstract][Full Text] [Related]
9. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection. Dabee S; Barnabas SL; Lennard KS; Jaumdally SZ; Gamieldien H; Balle C; Happel AU; Murugan BD; Williamson AL; Mkhize N; Dietrich J; Lewis DA; Chiodi F; Hope TJ; Shattock R; Gray G; Bekker LG; Jaspan HB; Passmore JS PLoS One; 2019; 14(4):e0213975. PubMed ID: 30947260 [TBL] [Abstract][Full Text] [Related]
10. Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi. Haddad LB; Tang JH; Davis NL; Kourtis AP; Chinula L; Msika A; Tegha G; Hosseinipour MC; Nelson JAE; Hobbs MM; Gajer P; Ravel J; De Paris K mSphere; 2023 Feb; 8(1):e0058522. PubMed ID: 36622252 [TBL] [Abstract][Full Text] [Related]
11. "It's already in your body and it's preventing": a qualitative study of African female adolescent's acceptability and preferences for proxy HIV prevention methods in Cape Town, South Africa. Fynn L; Gill K; Wallace M; Atujuna M; Duyver M; Ngcobo P; Spiegel H; Rinehart A; Hosek S; Bekker LG BMC Public Health; 2023 Nov; 23(1):2143. PubMed ID: 37919697 [TBL] [Abstract][Full Text] [Related]
12. Hormonal contraception and the risk of HIV acquisition among women in South Africa. Morrison CS; Skoler-Karpoff S; Kwok C; Chen PL; van de Wijgert J; Gehret-Plagianos M; Patel S; Ahmed K; Ramjee G; Friedland B; Lahteenmaki P AIDS; 2012 Feb; 26(4):497-504. PubMed ID: 22156973 [TBL] [Abstract][Full Text] [Related]
13. The contraceptive vaginal ring compared with the combined oral contraceptive pill: a comprehensive review of randomized controlled trials. Roumen FJ Contraception; 2007 Jun; 75(6):420-9. PubMed ID: 17519147 [TBL] [Abstract][Full Text] [Related]
14. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Myer L; Denny L; Wright TC; Kuhn L Int J Epidemiol; 2007 Feb; 36(1):166-74. PubMed ID: 17175547 [TBL] [Abstract][Full Text] [Related]
15. A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol. Weisberg E; Fraser IS; Mishell DR; Lacarra M; Darney P; Jackanicz TM Contraception; 1999 May; 59(5):305-10. PubMed ID: 10494484 [TBL] [Abstract][Full Text] [Related]
16. Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception. Balkus JE; Palanee-Phillips T; Reddy K; Siva S; Harkoo I; Nakabiito C; Kintu K; Nair G; Chappell C; Kiweewa FM; Kabwigu S; Naidoo L; Jeenarain N; Marzinke M; Soto-Torres L; Brown ER; Baeten JM J Acquir Immune Defic Syndr; 2017 Oct; 76(2):e47-e51. PubMed ID: 28542081 [TBL] [Abstract][Full Text] [Related]
17. Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome. Brooks JP; Edwards DJ; Blithe DL; Fettweis JM; Serrano MG; Sheth NU; Strauss JF; Buck GA; Jefferson KK Contraception; 2017 Apr; 95(4):405-413. PubMed ID: 27913230 [TBL] [Abstract][Full Text] [Related]
18. Vaginal microbiome-hormonal contraceptive interactions associate with the mucosal proteome and HIV acquisition. Noël-Romas L; Perner M; Molatlhegi R; Farr Zuend C; Mabhula A; Hoger S; Lamont A; Birse K; Berard A; McCorrister S; Westmacott G; Leslie A; Poliquin V; Heffron R; McKinnon LR; Burgener AD PLoS Pathog; 2020 Dec; 16(12):e1009097. PubMed ID: 33362285 [TBL] [Abstract][Full Text] [Related]
19. Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings. Thurman AR; Schwartz JL; Ravel J; Gajer P; Marzinke MA; Yousefieh N; Anderson SM; Doncel GF PLoS One; 2019; 14(5):e0217229. PubMed ID: 31107913 [TBL] [Abstract][Full Text] [Related]
20. Medroxyprogesterone acetate alters the vaginal microbiota and microenvironment in women and increases susceptibility to HIV-1 in humanized mice. Wessels JM; Lajoie J; Cooper MIJH; Omollo K; Felker AM; Vitali D; Dupont HA; Nguyen PV; Mueller K; Vahedi F; Kimani J; Oyugi J; Cheruiyot J; Mungai JN; Deshiere A; Tremblay MJ; Mazzulli T; Stearns JC; Ashkar AA; Fowke KR; Surette MG; Kaushic C Dis Model Mech; 2019 Oct; 12(10):. PubMed ID: 31537512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]